During severe systemic infection, steady-state hematopoiesis is switched to demand-adapted myelopoiesis, leading to increased myeloid progenitor proliferation and, depending on the context and type of pathogen, enhanced granulocytic or monocytic differentiation, respectively. We will review the recent advances in understanding direct and indirect mechanisms by which different pathogen signals are detected and subsequently translated into demand-adapted myelopoiesis.
INTRODUCTION
The hematopoietic system is maintained by a rare population of predominantly quiescent but intermittently actively cycling hematopoietic stem cells (HSCs) that give rise to several lineage-restricted hematopoietic progenitor cells, ultimately yielding cells of the various mature myeloid and lymphoid lineages [1] . As most of the mature hematopoietic cells are terminally differentiated, nondividing and short-lived, the unique functional organization of the hematopoietic system needs to ensure homeostatic cell counts in peripheral blood during steady state by enormous cellular multiplication that occurs during lineage maturation [1] . However, pathologic conditions that disturb the hematopoietic equilibrium such as bleeding or severe systemic infection induce demand-adapted hematopoietic response programs that not only counterbalance cell losses but also drastically increase cellular output to meet the specific needs during emergency situations [2] .
In contrast to uncomplicated bacterial and viral infections that are contained locally by innate and adaptive immune defense mechanisms, the response to severe systemic infection with classical Gram-positive or Gram-negative bacteria (e.g., Stapyhylococci or Enterobacteriaceae) leads to a number of well known and characteristic clinical phenomena, such as peripheral blood leukocytosis, neutrophilia, and 'left-shift' (i.e., the appearance of immature neutrophil precursor cells in the peripheral blood). These systemic signs of infection are caused by two complementary functional cascades launched upon severe systemic bacterial infection: neutrophil recruitment, which is beyond the scope of this review but has excellently been reviewed lately [3] , and 'emergency granulopoiesis'. Emergency granulopoiesis describes the processes leading to the de novo generation of granulocytes (most importantly neutrophils) and it is a prototypic example for demand-adapted hematopoiesis [4 & ]. However, during severe infections with other types of pathogens (i.e., intracellularly replicating bacteria, viruses etc.), the dominant myelopoietic response is an enhanced production of monocytes, that is, 'emergency monocytopoiesis', sometimes paralleled by suppression of granulopoiesis. Throughout this review we will thus use the term 'demand-adapted myelopoiesis' to describe infection-induced hematopoietic responses in general, and we will utilize the specific terms 'emergency granulopoiesis' and 'emergency monocytopoiesis' to specify the primary cellular outcome.
The essential first step in the initiation of demand-adapted myelopoiesis is detection of the presence of a pathogenic organism (e.g., bacteria, virus, and fungi) to indicate the emergency condition to the hematopoietic system, followed by a cascade of molecular events that induce increased proliferation and myeloid differentiation of hematopoietic progenitor cells. Despite the obvious fundamental importance of initiation of demandadapted myelopoiesis, its exact mechanisms have only begun to be elucidated over the last years. From a theoretical point of view, a putative cell type initiating demand-adapted myelopoiesis has to meet two requirements: it needs to have a high likelihood of encountering an invading pathogen and it has to be equipped with the molecular machinery for pathogen sensing and subsequent stimulation of myelopoiesis. Pattern recognition receptors such as Toll-like receptors (TLRs) sense pathogens through detection of highly conserved pathogen-associated molecular patterns triggering several molecular cascades critical for proper immune and hematopoietic responses to infection. In light of the broad distribution and cooccurrence of these two functional prerequisites among the various cells of the mammalian organism including hematopoietic and nonhematopoietic cells, two principal mechanisms of initiation of demandadapted myelopoiesis, that is, indirect and direct, can be considered. A model of indirect initiation of demand-adapted myelopoiesis would incorporate cells present in the bone marrow and/or the peripheral tissue acting solely as pathogen sensors but not generating myeloid offspring themselves. In this case, demand-adapted myelopoiesis is stimulated by secondary release of myelopoietic cytokines and growth factors from the pathogen sensing cell type. By contrast, direct pathogen sensing by hematopoietic stem and progenitor cells (HSPCs) would directly induce enhanced proliferation and myeloid-biased differentiation.
In this review, we will discuss the evidence for both models with an emphasis on recent findings revealing a complex system of multiple complementary mechanisms that have evolved to ensure proper hematopoietic responses toward potentially lifethreatening systemic infections.
INDIRECT INITIATION OF DEMAND-ADAPTED MYELOPOIESIS-PATHOGEN SENSING VIA HEMATOPOIETIC AND NONHEMATOPOIETIC CELLS
An abundance of studies conducted over the past decades has clearly demonstrated that steady-state myelopoiesis is driven via the well orchestrated activity of various myelopoietic growth factors [5, 6] . Of these, granulocyte colony-stimulating factor (G-CSF) is the best studied cytokine [7] and its essential role in governing steady-state granulopoiesis is demonstrated by a 70-90% reduction in circulating neutrophils in G-CSF-deficient (Csf3 À/À ) [8] and G-CSFR-deficient (Csf3r À/À ) [9] mice, respectively. However, the role of G-CSF during emergency granulopoiesis is less well established because of a shortage of conclusive experimental data. Although an older study revealed that G-CSFdeficient mice have a significantly attenuated granulopoietic response and increased lethality during
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Endothelial cells translate the detection of systemic Gram-negative bacterial infection into emergency granulopoiesis via
Myd88-dependent sensing of LPS and subsequent release of G-CSF.
ROS are released from bone marrow-resident Gr1 þ mature myeloid cells and promote emergency granulopoiesis independent of G-CSF.
Bone marrow mesenchymal stromal cells secrete IL-6 upon stimulation with IFNg released from CD8 þ cytotoxic T cells, and IL-6, in turn, promotes emergency monocytopoiesis from early HSPCs during systemic viral infection. In addition, IFNg directly acts on HSPCs favoring monocytic lineage differentiation.
HSPCs secrete various inflammatory cytokines and growth factors following direct stimulation with TLR2 and TLR4 agonists. HSPC-derived cytokines contribute to initiation of emergency granulopoiesis albeit under very specific experimental conditions. infection with Listeria monocytogenes compared with control mice [8, 10] , another study testing emergency granulopoiesis in the setting of systemic infection with Candida albicans did not detect differences in emergency granulopoiesis between Candida-infected G-CSF-deficient and control mice [11] . Data revealing that cytokines, most importantly G-CSF and macrophage colony-stimulating factor (M-CSF), not only provide survival and proliferative signals but are also able to directly instruct lineage choice in bipotent granulocyte-macrophage progenitors [12] , together with the abundant literature on highly-elevated serum levels of myelopoietic cytokines during systemic infection [4 & ,5] , strongly suggest a pivotal role of growth facto rs during emergency granulopoiesis. However, the identity of the pathogen-sensing and cytokine-releasing cell type has remained enigmatic. A popular assumption was that monocytes and tissueresident macrophages induce emergency granulopoiesis [5, 6] . Indeed, monocytes and macrophages possess all of the theoretical functional requirements, and most importantly, express pattern recognition receptors and granulopoietic cytokines [such as G-CSF, granulocyte-macrophage colony-stimulating factor (GM-CSF), and M-CSF] upon stimulation with pathogens [13] [14] [15] [16] . However, this notion has never been conclusively proven by stringent in-vivo experimentation. Only recently, the exact mechanism by which disseminated bacterial infection is sensed and translated into increased granulopoietic growth factor levels which, in turn, stimulate the switch from steady-state to emergency granulopoiesis has been clarified. We have generated bone marrow chimeric animals with a selective Toll-like receptor 4 (Tlr4) or myeloid differentiation primary response gene 88 (Myd88) deficiency in either hematopoietic or nonhematopoietic tissues [17,18 && ]. Following stimulation with high doses of lipopolysaccharide (LPS) to mimic severe systemic Gram-negative bacterial infection, we could observe that while LPS-sensing by hematopoietic cells is dispensable for the induction of emergency granulopoiesis, Tlr4 and Myd88 expression within an irradiation-resistant nonhematopoietic cell type is absolutely required for this process. Moreover, the data also indicated that G-CSF is the primary cytokine driving LPS-induced emergency granulopoiesis [17] . To determine the exact identity of this nonhematopoietic cell type, we generated tissue-specific Myd88 knockout mice using Cre-loxP recombination targeting several candidate nonhematopoietic cell types including Nestin þ mesenchymal stromal cells (MSCs) [19, 20] , CXCL12-abundant reticular cells [21] , and endothelial cells [22, 23] , all of which have been implicated in regulating several aspects of hematopoiesis [24 && ,25] . The data unambiguously revealed that endothelial cells are the primary LPSsensing cell type and the essential source of G-CSF in the course of LPS-induced emergency granulopoiesis ( Fig. 1a) . Although LPS-induced emergency granulopoiesis was completely dependent on endothelial cell-intrinsic Myd88 expression, emergency granulopoiesis induced by Escherichia coli was still detectable in the setting of Myd88 deficiency, however, at a significantly reduced magnitude and, most importantly, despite the lack of measurable G-CSF serum levels [18 && ]. Consequently, alternative, G-CSF-independent pathways to initiate emergency granulopoiesis in the context of infection with live bacteria exist.
Interestingly, a recent study by Kwak et al. [26 & ] revealed that mature myeloid cell-derived reactive oxygen species (ROS) externally regulate the proliferation of myeloid progenitors during emergency granulopoiesis. The authors found that stimulation with heat-inactivated Gram-negative bacterium E. coli leads to elevated levels of ROS within the bone marrow, and that ROS are released from Gr1 þ myeloid cells in a nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. Of note, ROS-induced emergency granulopoiesis is apparently independent from G-CSFinduced emergency granulopoiesis and this finding provides a possible explanation for the G-CSFindependent emergency granulopoietic response observed by us in endothelial cell-specific Myd88 knockout mice following infection with E. coli. Thus, ROS and G-CSF cooperate in regulating emergency granulopoiesis following infection with E. coli. Moreover, the study by Kwak et al. demonstrates that mature myeloid Gr1 þ cells regulate their own replenishment during emergency granulopoiesis via ROS-mediated stimulation of HSPCs (Fig. 1b) .
In contrast to bacterial infection-induced emergency granulopoiesis, peripheral blood monocytosis is often observed during viral infection, suggesting initiation of an emergency monocytopoiesis program. De Bruin et al. [27] found that T cell-derived IFNg during infection with lymphocytic choriomeningitis virus directly modulates lineage outcome in common myeloid progenitors and granulocytemacrophage progenitors favoring monocyte generation at the expense of granulocyte production. On the molecular level, IFNg suppresses G-CSF signal transduction via suppressor of cytokine signaling 3-dependent inhibition of signal transducer and activator of transcription 3 phosphorylation and concomitant induction of monocytopoiesis-stimulating transcription factors in myeloid progenitors [27] .
Along similar lines, results from a recent study have not only shed new light on the role of IL-6 during emergency monocytopoiesis but also demonstrated unexpected cellular sources of this cytokine. IL-6 has been mainly implicated in the regulation of steady-state and emergency granulopoiesis [28, 29] . It was shown that Il6 À/À mice have an impaired neutrophil response after C. albicans infection [30] , and mice simultaneously lacking G-CSF, GM-CSF and IL-6 harbor a more profound defect in granulopoiesis compared with mice with a combined absence of G-CSF and GM-CSF as demonstrated by in-vitro experimentation [31] . However, Schürch et al. [32 && ] studied the hematopoietic response during systemic viral infection and found that IFNg released by cytotoxic CD8 þ T cells activates the hematopoietic system and induces myeloid-biased differentiation favoring mainly monocytopoiesis. Moreover, using reciprocal bone marrow chimeric animals the authors could show that IFNg does not directly act on HSPCs but stimulates an irradiation-resistant cell type to release IL-6, which in turn, mediates increased myelopoiesis with monocyte-biased differentiation. To identify the IL-6-secreting cell type, the authors isolated bone marrow MSCs, osteoblasts, and endothelial cells of wild-type and IFNg-receptor knockout mice (Ifngr À/À ) and stimulated these cell populations ex vivo with IFNg. Notably, IL-6 secretion was only observed in supernatants from wild-type MSC cultures. Altogether, these data corroborate a model (Fig. 1c) , in which IFNg released from CD8 þ T cells induces IL-6 secretion from bone marrow MSCs that stimulates enhanced myelopoiesis and monocytic differentiation [32 && ].
DIRECT INITIATION OF DEMAND-ADAPTED MYELOPOIESIS-PATHOGEN SENSING BY HEMATOPOIETIC STEM AND PROGENITOR CELLS
A solid body of evidence demonstrates that HSPCs express TLRs [2, 33, 34] and that TLR stimulati on leads to proliferation and myeloid-biased differentiation of mouse [33] and human HSPCs [35, 36] . In conjunction with the well established migratory capacity of HSCs, regularly egressing and re-entering the bone marrow [37] , a potential physiological function might be surveillance of tissues for the presence of invading pathogens followed by generation of myeloid offspring at the site of pathogen entry. Indeed, one study suggested such a mechanism, though under very special experimental settings, involving transplantation under the kidney capsule of ex-vivo prestimulated mouse HSPCS followed by prolonged in-vivo stimulation with LPS. Such treatment led to the detection clusters of myeloid cells within the kidney [38] .
Additional support for a direct role of pathogen sensing by HSPCs has emerged recently. Zhao et al. employed a high-throughput, microfluidic-based platform to simultaneously measure 12 cytokines secreted from fluorescence-activated cell sortingisolated HSPC populations upon ex-vivo stimulation with LPS and/or TLR2 agonist Pam3CSK4 [39 && ] . Surprisingly, the authors could observe significant secretion of a variety of cytokines including IL-1b, IL-2, IL-4, IL-6, IL-12, IL-17A, IFNg, TNFa, and GM-CSF at the single-cell level following TLR agonist stimulation. Notably, although the most immature immunophenotypically defined long-term HSCs were unresponsive to TLR agonist stimulation, cytokine release was most abundant in short-term HSCs and multipotent progenitors. Among the measured cytokines, IL-6 was most prominently detected both in terms of percentage of individual HSPCs expressing the cytokine as well as in the amount of secreted IL-6. The authors set out to test the biological relevance of HSPC-derived IL-6 but faced the experimental problem that it is impossible with current technology to abrogate IL-6 specifically in a defined HSPC population leaving other cell types unaffected. Therefore, the authors conceived an experimental setting, in which irradiated and consequently severe leukopenic hosts were transplanted with Lin À cKit þ cells from either wild-type or Il6 À/À mice. Subsequently, recipient mice were stimulated with LPS. Although mice transplanted with Il6 À/À cells showed some evidence for emergency granulopoiesis, the response was severely diminished compared with mice receiving wild-type cells [39 && ]. Although these results suggest that HSPC-derived IL-6 is able to contribute to emergency granulopoiesis under very defined experimental conditions, that is, in an irradiated and severely leukopenic host, the relative contribution of other cellular sources of IL-6 such as bone marrow stromal cell populations in a more natural setting remains to be determined. Nevertheless, the study by Zhao et al. suggests that HSPCs might not only be targets for growth factor signals but, indeed, directly sense pathogen signals with the consequence of delivering cytokine signals in an autocrine and/or paracrine manner (Fig. 1d ).
CONCLUSION
Adaptation of the blood-forming system to severe systemic, life-threatening infection, that is, one of the strongest naturally-occurring hematopoietic stressors, has been extensively studied over the past decades as outlined in this review. Recent findings have drawn a complex picture, in which various hematopoietic and nonhematopoietic cell types interact in an intricate manner to shape an appropriate hematopoietic response to a specific emergency situation (Fig. 1a-d) . However, several important questions have remained unanswered and some limitations need to be taken into consideration when evaluating available data. Therefore, we suggest particularly addressing the following issues when conceiving new experiments to further elucidate our understanding of demandadapted myelopoiesis.
First, it will be important to use appropriate types of pathogens given the fact that previous results suggested pathogen-specific differences in emergency hematopoietic responses. For instance, while the studies using pathogens such as intracellular bacterium L. monocytogenes and yeast C. albicans certainly yielded valuable results, both pathogens are less frequent in causing hematopoietic emergency responses compared with common pathogenic bacteria such as Staphylococci and Enterobacteriacae, and potential studies using the latter might yield different results. Second, we suggest to evaluate and report findings on proliferation of HSPCs in the bone marrow and evidence for enhanced cell turnover together with results of peripheral blood counts. Isolated quantitative differences in peripheral blood might be solely a consequence of mobilization of preformed myeloid cells from storage pools such as the bone marrow. Similarly, a change in numbers of myeloid progenitor cells in the bone marrow without changes in peripheral blood counts or indications for accelerated cell turnover as measured by, for instance, 5-bromo-2 0 -deoxyuridine incorporation, would also be insufficient. Third, it will be interesting to address the question of where pathogen sensing and production of myelopoiesis-stimulating cytokines primarily takes place, that is, inside or outside the bone marrow, and whether both possibilities might differ with respect to excess of infection and the functional outcome.
In summary, further studies are warranted to elucidate the relative contribution of the various above-described mechanisms operating to regulate the switch from steady-state to demand-adapted myelopoiesis with the overall goal to ensure proper context-and pathogen-dependent functionality of the hematopoietic system. In addition, research on this holds the promise to devise new therapeutic strategies to treat human infectious and hematologic diseases.
